Big Ten Cancer Research Consortium

The UW Carbone Cancer Center (UWCCC) participates in the Big Ten Cancer Research Consortium. The Consortium unites Big Ten cancer centers to transform the conduct of cancer research through collaborative, hypothesis-driven, highly translational oncology trials. The Consortium’s strengths lie in leveraging the scientific and clinical expertise of Big Ten universities.

Benefits of UWCCC membership to the Consortium includes:
  • Expedited contracting by virtue of membership
  • Planned consolidated IRB review
  • Organized clinical trial working groups
  • Ability to share specimens with clinically annotated data
  • Avenue for development of junior faculty
  • Opportunity to quickly open trials across 13 academic institutions
In addition to UWCCC, the following universities and cancer centers comprise the Big Ten Cancer Research Consortium:
  • Indiana University (Indiana University Melvin and Bren Simon Comprehensive Cancer Center)
  • Michigan State University (Breslin Cancer Center)
  • Northwestern University (Robert H. Lurie Comprehensive Cancer Center)
  • The Ohio State University (The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
  • Penn State University (Penn State Hershey Cancer Institute)
  • Purdue University (Purdue University Center for Cancer Research)
  • Rutgers University (Rutgers Cancer Institute of New Jersey)
  • University of Illinois at Chicago (University of Illinois Cancer Center)
  • University of Illinois at Urbana-Champaign (The Cancer Center at Illinois)
  • University of Iowa (Holden Comprehensive Cancer Center)
  • University of Maryland (Marlene and Stewart Greenebaum Comprehensive Cancer Center)
  • University of Michigan (University of Michigan Rogel Cancer Center)
  • University of Minnesota (Masonic Cancer Center)
  • University of Nebraska (Fred & Pamela Buffett Cancer Center)

News & Developments

UW @ the Big Ten